2,851
edits
Line 100: | Line 100: | ||
===Formulation of Enhanced Bioavailability=== | ===Formulation of Enhanced Bioavailability=== | ||
The low bioavailability of quercetin raises questions about the clinical relevance of its potential health benefits observed in vitro and in animal studies. Therefore, several strategies have been explored to enhance the absorption and stability of quercetin. These include the development of various formulations and delivery systems such as: | |||
{| class="wikitable" style="width:100%; text-align:center;" | {| class="wikitable" style="width:100%; text-align:center;" |